Metabolic Syndrome Exacerbates Central Arterial Stiffness in HIV-1 Infected Patients Receiving Antiretroviral Treatment But Not in HIV-1 Treatment-Naive Patients in Sub-Saharan Africa

dc.contributor.advisorVanGuilder, Gary
dc.contributor.authorNoeldner, Joelle
dc.contributor.authorHersant, Jenna
dc.contributor.authorMsoka, Titus
dc.date.accessioned2012-09-11T19:43:38Z
dc.date.available2012-09-11T19:43:38Z
dc.date.issued2012-04
dc.descriptionColor poster with text, tables, and graphs.en
dc.description.abstractMetabolic syndrome (MetS), a clustering of cardiovascular risk factors, is becoming increasingly prevalent with HIV-1 in resource-limited settings, and higher rates are observed in HIV-1-infected patients who are undergoing antiretroviral treatment (ART). Increased blood vessel stiffness may contribute to heart disease in HIV-infected patients taking ART. Therefore, the aim of this study was to determine whether blood vessel stiffness is increased in HIV-1-infected patients treated with ART, and if so, whether the presence of MetS exaggerates arterial stiffness in this population.en
dc.description.sponsorshipUniversity of Wisconsin--Eau Claire Office of Research and Sponsored Programs.en
dc.identifier.urihttp://digital.library.wisc.edu/1793/62896
dc.language.isoen_USen
dc.relation.ispartofseriesUSGZE AS589en
dc.subjectHIV infections--Africa, Sub-Sahran--Treatmenten
dc.subjectMetabolic syndromeen
dc.subjectHIV infections--Africa, Sub-Sahran--Complicationsen
dc.subjectAntiretroviral agentsen
dc.subjectAfrica, Sub-Saharanen
dc.subjectPosters
dc.titleMetabolic Syndrome Exacerbates Central Arterial Stiffness in HIV-1 Infected Patients Receiving Antiretroviral Treatment But Not in HIV-1 Treatment-Naive Patients in Sub-Saharan Africaen
dc.typePresentationen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
HersantSpr2012.pdf
Size:
666.36 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.03 KB
Format:
Item-specific license agreed upon to submission
Description: